Chapter 1: Psoriasis Biosimilars Market Overview

1.1 Global Market Size of Psoriasis Biosimilars Market (2021-2033)
1.2 Overview and Scope of Psoriasis Biosimilars Market
1.3 Classification of Psoriasis Biosimilars Market by Drug Class
1.3.1 Global Psoriasis Biosimilars Market Revenue Comparison by Drug Class (2026-2033)
1.3.2 Global Psoriasis Biosimilars Market Revenue Market Share by Drug Class in 2025
1.3.3 TNF-Alpha Inhibitor Biosimilars
1.3.4 Interleukin Inhibitor Biosimilars
1.3.5 Other Biosimilars
1.4 Global Psoriasis Biosimilars Market by Disease Type
1.4.1 Global Psoriasis Biosimilars Market Size and Market Share Comparison by Disease Type (2026-2033)
1.4.2 Plaque Psoriasis
1.4.3 Guttate Psoriasis
1.4.4 Inverse Psoriasis
1.4.5 Pustular Psoriasis
1.4.6 Erythrodermic Psoriasis
1.5 Classification of Psoriasis Biosimilars Market by Route of Administration
1.5.1 Global Psoriasis Biosimilars Market Revenue Comparison by Route of Administration (2026-2033)
1.5.2 Global Psoriasis Biosimilars Market Revenue Market Share by Route of Administration in 2025
1.5.3 Subcutaneous
1.5.4 Intravenous
1.5.5 Oral
1.5.6 Topical
1.6 Classification of Psoriasis Biosimilars Market by Distribution Channel
1.6.1 Global Psoriasis Biosimilars Market Revenue Comparison by Distribution Channel (2026-2033)
1.6.2 Global Psoriasis Biosimilars Market Revenue Market Share by Distribution Channel in 2025
1.6.3 Hospital Pharmacies
1.6.4 Retail Pharmacies
1.6.5 Online Pharmacies
1.7 Global Psoriasis Biosimilars Market by Regions
1.7.1 Global Psoriasis Biosimilars Market Size (USD Billion) Comparison by Regions (2026-2033)
1.7.2 North America (USA, Canada, and Mexico) Psoriasis Biosimilars Market Status and Prospect (2021-2033)
1.7.3 Europe (Germany, France, UK, Italy, Spain, Rest of Europe) Psoriasis Biosimilars Market Status and Prospect (2021-2033)
1.7.4 Asia Pacific (China, Japan, India, South Korea, Rest of Asia Pacific) Psoriasis Biosimilars Market Status and Prospect (2021-2033)
1.7.5 Latin America (Brazil, Rest of Latin America) Psoriasis Biosimilars Market Status and Prospect (2021-2033)
1.7.6 Middle East & Africa (GCC, South Africa, Rest of Middle East & Africa) Psoriasis Biosimilars Market Status and Prospect (2021-2033)
1.8 Global Market Size of Psoriasis Biosimilars Market (2021-2033)

Chapter 2: Market Dynamics

2.1 Market Drivers
2.2 Market Restraints
2.3 Value Chain Analysis
2.4 Market Opportunities
2.5 SWOT Analysis
2.5.1 Strengths
2.5.2 Weaknesses
2.5.3 Opportunities
2.5.4 Threats
2.6 Top Investment Pockets
2.7 Key Impacting Factor
2.8 Porter's Five Forces Analysis
2.8.1 Competitive Rivalry within the Industry
2.8.2 Threat of New Entrants
2.8.3 Bargaining Power of Suppliers
2.8.4 Bargaining Power of Buyers
2.8.5 Threat of Substitute Products or Services
2.9 Key Market Strategies
2.9.1 Key Market Strategies, 2025 (%)
2.10 PESTEL Analysis
2.10.1 Political Factors
2.10.2 Economic Factors
2.10.3 Social Factors
2.10.4 Technological Factors
2.10.5 Environmental Factors
2.10.6 Legal Factors
2.10.7 PESTEL Analysis

Chapter 3: Company Profiles

3.1 Pfizer Inc.
3.1.1 Company Basic Information and Its Competitors
3.1.2 Pfizer Inc. Product Category
3.1.3 Pfizer Inc. Psoriasis Biosimilars Market Revenue (2023-2025)
3.1.4 Recent Developments
3.1.5 Main Business/Business Overview
3.2 Amgen Inc.
3.3 Sandoz Group AG
3.4 Fresenius Kabi AG
3.5 Intas Pharmaceuticals Ltd. (Accord Biopharma)
3.6 STADA Arzneimittel AG
3.7 Aurobindo Pharma Ltd.
3.8 Dr. Reddy's Laboratories Ltd.
3.9 Samsung Bioepis Co., Ltd.
3.10 Zydus Lifesciences Ltd.
3.11 Celltrion Inc.
3.12 Bio-Thera Solutions Ltd.
3.13 Coherus BioSciences Inc.
3.14 mAbxience S.A.
3.15 Alvotech hf.
3.16 Biocon Biologics Ltd.
3.17 Viatris Inc.
3.18 Boehringer Ingelheim International GmbH
3.19 Organon & Co.
3.20 Teva Pharmaceutical Industries Ltd.
3.21 Lupin Limited
3.22 Gedeon Richter Plc.
3.23 Prestige Biopharma Ltd.
3.24 Bio-Gen Extracts Pvt. Ltd.
3.25 Kashiv BioSciences LLC
3.26 Kern Pharma S.L.
3.27 Formycon AG
3.28 Polpharma Biologics S.A.
3.29 Innovent Biologics Inc.
3.30 Shanghai Henlius Biotech, Inc.

Chapter 4: Global Psoriasis Biosimilars Market Competition, by Players

4.1 Global Psoriasis Biosimilars Market Revenue and Share by Players (2023-2025)
4.2 Player Positioning
4.3 Top 5 Psoriasis Biosimilars Market Players Market Share Market Concentration Rate
4.3.1 Top 3 Psoriasis Biosimilars Market Players Market Share
4.3.2 Top 5 Psoriasis Biosimilars Market Players Market Share

Chapter 5: Global Psoriasis Biosimilars Market Size by Regions

5.1 Global Psoriasis Biosimilars Market Revenue, and Market Share by Regions
5.2 North America Psoriasis Biosimilars Market Revenue, and Growth Rate (2021-2025)
5.3 Europe Psoriasis Biosimilars Market Revenue, and Growth Rate (2021-2025)
5.4 Asia Pacific Psoriasis Biosimilars Market Revenue, and Growth Rate (2021-2025)
5.5 Latin America Psoriasis Biosimilars Market Revenue, and Growth Rate (2021-2025)
5.6 Middle East & Africa Psoriasis Biosimilars Market Revenue, and Growth Rate (2021-2025)

Chapter 6: North America Psoriasis Biosimilars Market Revenue by Countries

6.1 North America Psoriasis Biosimilars Market Revenue, by Countries (2021-2025)
6.2 USA Psoriasis Biosimilars Market Revenue and Growth Rate (2021-2025)
6.3 Canada Psoriasis Biosimilars Market Revenue and Growth Rate (2021-2025)
6.4 Mexico Psoriasis Biosimilars Market Revenue and Growth Rate (2021-2025)
6.5 North America Psoriasis Biosimilars Market Revenue and Market Share by Drug Class (2021-2025)
6.6 North America Psoriasis Biosimilars Market Share by Disease Type (2021-2025)
6.7 North America Psoriasis Biosimilars Market Share by Route of Administration (2021-2025)
6.8 North America Psoriasis Biosimilars Market Share by Distribution Channel (2021-2025)

Chapter 7: Europe Psoriasis Biosimilars Market Revenue by Countries

7.1 Europe Psoriasis Biosimilars Market Revenue, by Countries (2021-2025)
7.2 Germany Psoriasis Biosimilars Market Revenue and Growth Rate (2021-2025)
7.3 France Psoriasis Biosimilars Market Revenue and Growth Rate (2021-2025)
7.4 UK Psoriasis Biosimilars Market Revenue and Growth Rate (2021-2025)
7.5 Italy Psoriasis Biosimilars Market Revenue and Growth Rate (2021-2025)
7.6 Spain Psoriasis Biosimilars Market Revenue and Growth Rate (2021-2025)
7.7 Rest of Europe Psoriasis Biosimilars Market Revenue and Growth Rate (2021-2025)
7.8 Europe Psoriasis Biosimilars Market Revenue and Market Share by Drug Class (2021-2025)
7.9 Europe Psoriasis Biosimilars Market Share by Disease Type (2021-2025)
7.10 Europe Psoriasis Biosimilars Market Share by Route of Administration (2021-2025)
7.11 Europe Psoriasis Biosimilars Market Share by Distribution Channel (2021-2025)

Chapter 8: Asia Pacific Psoriasis Biosimilars Market Revenue by Countries

8.1 Asia Pacific Psoriasis Biosimilars Market Revenue, by Countries (2021-2025)
8.2 China Psoriasis Biosimilars Market Revenue and Growth Rate (2021-2025)
8.3 Japan Psoriasis Biosimilars Market Revenue and Growth Rate (2021-2025)
8.4 India Psoriasis Biosimilars Market Revenue and Growth Rate (2021-2025)
8.5 South Korea Psoriasis Biosimilars Market Revenue and Growth Rate (2021-2025)
8.6 Rest of Asia Pacific Psoriasis Biosimilars Market Revenue and Growth Rate (2021-2025)
8.7 Asia Pacific Psoriasis Biosimilars Market Revenue and Market Share by Drug Class (2021-2025)
8.8 Asia Pacific Psoriasis Biosimilars Market Share by Disease Type (2021-2025)
8.9 Asia Pacific Psoriasis Biosimilars Market Share by Route of Administration (2021-2025)
8.10 Asia Pacific Psoriasis Biosimilars Market Share by Distribution Channel (2021-2025)

Chapter 9: Latin America Psoriasis Biosimilars Market Revenue by Countries

9.1 Latin America Psoriasis Biosimilars Market Revenue, by Countries (2021-2025)
9.2 Brazil Psoriasis Biosimilars Market Revenue and Growth Rate (2021-2025)
9.3 Rest of Latin America Psoriasis Biosimilars Market Revenue and Growth Rate (2021-2025)
9.4 Latin America Psoriasis Biosimilars Market Revenue and Market Share by Drug Class (2021-2025)
9.5 Latin America Psoriasis Biosimilars Market Share by Disease Type (2021-2025)
9.6 Latin America Psoriasis Biosimilars Market Share by Route of Administration (2021-2025)
9.7 Latin America Psoriasis Biosimilars Market Share by Distribution Channel (2021-2025)

Chapter 10: Middle East & Africa Psoriasis Biosimilars Market Revenue by Countries

10.1 Middle East & Africa Psoriasis Biosimilars Market Revenue by Countries (2021-2025)
10.2 GCC Psoriasis Biosimilars Market Revenue and Growth Rate (2021-2025)
10.3 South Africa Psoriasis Biosimilars Market Revenue and Growth Rate (2021-2025)
10.4 Rest of Middle East & Africa Psoriasis Biosimilars Market Revenue and Growth Rate (2021-2025)
10.5 Middle East & Africa Psoriasis Biosimilars Market Revenue and Market Share by Drug Class (2021-2025)
10.6 Middle East & Africa Psoriasis Biosimilars Market Share by Disease Type (2021-2025)
10.7 Middle East & Africa Psoriasis Biosimilars Market Share by Route of Administration (2021-2025)
10.8 Middle East & Africa Psoriasis Biosimilars Market Share by Distribution Channel (2021-2025)

Chapter 11: Global Psoriasis Biosimilars Market Segment by Drug Class

11.1 Global Psoriasis Biosimilars Market Revenue and Market Share by Drug Class (2021-2025)
11.2 TNF-Alpha Inhibitor Biosimilars
11.2.1 Global TNF-Alpha Inhibitor Biosimilars Market Revenue by Regions (2021-2025)
11.3 Interleukin Inhibitor Biosimilars
11.3.1 Global Interleukin Inhibitor Biosimilars Market Revenue by Regions (2021-2025)
11.4 Other Biosimilars
11.4.1 Global Other Biosimilars Market Revenue by Regions (2021-2025)
11.5 Global Psoriasis Biosimilars Market Forecast by Drug Class (2026-2033)

Chapter 12: Global Psoriasis Biosimilars Market Segment by Disease Type

12.1 Global Psoriasis Biosimilars Market Share by Disease Type (2021-2025)
12.2 Plaque Psoriasis
12.2.1 Global Plaque Psoriasis Market Revenue by Regions (2021-2025)
12.3 Guttate Psoriasis
12.3.1 Global Guttate Psoriasis Market Revenue by Regions (2021-2025)
12.4 Inverse Psoriasis
12.4.1 Global Inverse Psoriasis Market Revenue by Regions (2021-2025)
12.5 Pustular Psoriasis
12.5.1 Global Pustular Psoriasis Market Revenue by Regions (2021-2025)
12.6 Erythrodermic Psoriasis
12.6.1 Global Erythrodermic Psoriasis Market Revenue by Regions (2021-2025)
12.7 Psoriasis Biosimilars Market Forecast by Disease Type (2026-2033)

Chapter 13: Global Psoriasis Biosimilars Market Segment by Route of Administration

13.1 Global Psoriasis Biosimilars Market Revenue and Market Share by Route of Administration (2021-2025)
13.2 Subcutaneous
13.2.1 Global Subcutaneous Market Revenue by Regions (2021-2025)
13.3 Intravenous
13.3.1 Global Intravenous Market Revenue by Regions (2021-2025)
13.4 Oral
13.4.1 Global Oral Market Revenue by Regions (2021-2025)
13.5 Topical
13.5.1 Global Topical Market Revenue by Regions (2021-2025)
13.6 Psoriasis Biosimilars Market Forecast by Route of Administration (2026-2033)

Chapter 14: Global Psoriasis Biosimilars Market Segment by Distribution Channel

14.1 Global Psoriasis Biosimilars Market Revenue and Market Share by Distribution Channel (2021-2025)
14.2 Hospital Pharmacies
14.2.1 Global Hospital Pharmacies Market Revenue by Regions (2021-2025)
14.3 Retail Pharmacies
14.3.1 Global Retail Pharmacies Market Revenue by Regions (2021-2025)
14.4 Online Pharmacies
14.4.1 Global Online Pharmacies Market Revenue by Regions (2021-2025)
14.5 Psoriasis Biosimilars Market Forecast by Distribution Channel (2026-2033)

Chapter 15: Global Psoriasis Biosimilars Market Size Forecast (2026-2033)

15.1 Global Psoriasis Biosimilars Market Size Forecast (2026-2033)
15.2 Global Psoriasis Biosimilars Market Revenue Forecast by Regions (2026-2033)
15.3 North America Psoriasis Biosimilars Market Revenue Forecast (2026-2033)
15.3.1 North America Market Revenue Forecast by Country (2026-2033)
15.3.2 North America Market Revenue Forecast by Drug Class (2026-2033)
15.3.3 North America Market Revenue Forecast by Disease Type (2026-2033)
15.3.4 North America Market Revenue Forecast by Route of Administration (2026-2033)
15.3.5 North America Market Revenue Forecast by Distribution Channel (2026-2033)
15.4 Europe Psoriasis Biosimilars Market Revenue Forecast (2026-2033)
15.4.1 Europe Market Revenue Forecast by Country (2026-2033)
15.4.2 Europe Market Revenue Forecast by Drug Class (2026-2033)
15.4.3 Europe Market Revenue Forecast by Disease Type (2026-2033)
15.4.4 Europe Market Revenue Forecast by Route of Administration (2026-2033)
15.4.5 Europe Market Revenue Forecast by Distribution Channel (2026-2033)
15.5 Asia Pacific Psoriasis Biosimilars Market Revenue Forecast (2026-2033)
15.5.1 Asia Pacific Market Revenue Forecast by Country (2026-2033)
15.5.2 Asia Pacific Market Revenue Forecast by Drug Class (2026-2033)
15.5.3 Asia Pacific Market Revenue Forecast by Disease Type (2026-2033)
15.5.4 Asia Pacific Market Revenue Forecast by Route of Administration (2026-2033)
15.5.5 Asia Pacific Market Revenue Forecast by Distribution Channel (2026-2033)
15.6 Latin America Psoriasis Biosimilars Market Revenue Forecast (2026-2033)
15.6.1 Latin America Market Revenue Forecast by Country (2026-2033)
15.6.2 Latin America Market Revenue Forecast by Drug Class (2026-2033)
15.6.3 Latin America Market Revenue Forecast by Disease Type (2026-2033)
15.6.4 Latin America Market Revenue Forecast by Route of Administration (2026-2033)
15.6.5 Latin America Market Revenue Forecast by Distribution Channel (2026-2033)
15.7 Middle East & Africa Psoriasis Biosimilars Market Revenue Forecast (2026-2033)
15.7.1 Middle East & Africa Market Revenue Forecast by Country (2026-2033)
15.7.2 Middle East & Africa Market Revenue Forecast by Drug Class (2026-2033)
15.7.3 Middle East & Africa Market Revenue Forecast by Disease Type (2026-2033)
15.7.4 Middle East & Africa Market Revenue Forecast by Route of Administration (2026-2033)
15.7.5 Middle East & Africa Market Revenue Forecast by Distribution Channel (2026-2033)

Chapter 16: Premium Analyst Insights

16.1 Key Market Insights on Drug Class Segment
16.1.1 Fastest Growing Segment
16.1.2 Largest Segment
16.2 Key Market Insights on Disease Type Segment
16.2.1 Fastest Growing Segment
16.2.2 Largest Segment
16.3 Key Market Insights on Regional Overview
16.3.1 Fastest Growing Region
16.3.2 Largest Region
16.3.3 Fastest Growing Country
16.3.4 Largest Country
16.4 Competitive Intelligence

Chapter 17: Appendix

17.1 Research Process
17.2 Primary and Secondary Research
17.2.1 Primary Research
17.2.2 Secondary Research
17.3 Market Size Estimation
17.4 Assumptions & Exclusions
17.5 Disclaimer